Current NDC auxiliary source row compounder:992

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69389-064
Product Ndc: 69389-064
Product Ndc Digits: 69389064
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Sarracenia Purpurea
Proprietary Name Suffix: [empty]
Nonproprietary Name: Sarracenia Purpurea
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRA-ARTICULAR; INTRAMUSCULAR; SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: US Specialty Formulations LLC
Establishment Name: US Specialty Formulations LLC
Establishment Fei: [empty]
Substance Name: SARRACENIA PURPUREA
Active Ingredients Info: 5 mg/1 mL
History Active Ingredients Raw: SARRACENIA PURPUREA
History Active Ingredients Info Raw: 5 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 69389-064-22
Package Ndc: 69389-064-22
Package Ndc Digits: 6938906422
Package Ndc11: 69389006422
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (69389-064-22)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:992
Source Row Number: 992
Source Row Hash: b95249f8375289be905e96a31607fd55177dbc2f6e3d4d9a69678e5da099308f
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRA-ARTICULAR; INTRAMUSCULAR; SUBCUTANEOUS",
    "PRODUCTNDC": "69389-064",
    "DEASCHEDULE": "",
    "LABELERNAME": "US Specialty Formulations LLC",
    "SUBSTANCENAME": "SARRACENIA PURPUREA",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "69389-064-22",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Sarracenia Purpurea",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Sarracenia Purpurea",
    "PACKAGEDESCRIPTION": "10 mL in 1 VIAL, MULTI-DOSE (69389-064-22) ",
    "ACTIVEINGREDIENTSINFO": "5 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:992
Source Row Number: 992
Status Scope: package
Lookup Ndc: 69389-064-22
Lookup Ndc Digits: 6938906422
Product Ndc: 69389-064
Product Ndc Digits: 69389064
Package Ndc: 69389-064-22
Package Ndc Digits: 6938906422
Package Ndc11: 69389006422
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: b95249f8375289be905e96a31607fd55177dbc2f6e3d4d9a69678e5da099308f
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51